Dezapelisib
Dezapelisib (NCB040093) is a potent inhibitor of phosphatidylinositol 3-kinase δ (PI3Kδ) . Dezapelisib is a promising research strategy for select R/R B-cell lymphomas[1].
Product Specifications
CAS Number
1262440-25-4
Product Name Alternative
INCB040093
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dezapelisib.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](C1=C(C2=CC(F)=CC=C2)C(N3C(SC=C3C)=N1)=O)NC4=C5C(N=CN5)=NC=N4
Molecular Formula
C20H16FN7OS
Molecular Weight
421.45
References & Citations
[1]Phillips TJ, et al. Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma. Blood. 2018;132 (3) :293-306.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARO-A17802-01 50 µg
Anti-PRRSV RNA-directed RNA polymerase/NSP9 VHH (Nb8)
Sign In for Pricing
View Details ARO-A17802-02 100 µg
Anti-PRRSV RNA-directed RNA polymerase/NSP9 VHH (Nb8)
Sign In for Pricing
View Details ARO-A17802-03 1 mg
Anti-PRRSV RNA-directed RNA polymerase/NSP9 VHH (Nb8)
Sign In for Pricing
View Details 
